Fig. 7
From: Mass production of IgY-containing tablets for COVID-19 transmission control
(A) Coomassie stained LDS-PAGE (left) and Western Blot (right) of recombinant whole S1 variants. Each lane is loaded with 2 ug targeted amount. All samples were reduced. Western blot was performed using anti-S1 IgY as the primary antibody. (B) Immunoblot of RBD and NTD variants against anti-S1 IgY (left) and control IgY (right). Original full-length images can be seen in Figure S1.
